Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
12-CdA, 2-chloro-2'-deoxy-beta-D-adenosine2件: Adenosine (beta-D-Adenosine),
Cladribine (2-chloro-2′-deoxy-adenosine)		2件: Adenosine (Adenosine),
Cladribine 💬 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
22-CdA, 2-chloro-2'-deoxy-ß-D-adenosine2件: Adenosine (beta-D-Adenosine),
Cladribine (2-chloro-2′-deoxy-adenosine)		2件: Adenosine (Adenosine),
Cladribine 💬 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
32-CdA, 2-chloro-2?-deoxy-beta-D-adenosine2件: Adenosine (beta-D-Adenosine),
Cladribine (2-chloro-2′-deoxy-adenosine)		2件: Adenosine (Adenosine),
Cladribine 💬 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
42-CdA, 2-chloro-2?-deoxy-ß-D-adenosine2件: Adenosine (beta-D-Adenosine),
Cladribine (2-chloro-2′-deoxy-adenosine)		2件: Adenosine (Adenosine),
Cladribine 💬 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
52-CdA, 2-chloro-2’-deoxy-beta-D-adenosine2件: Adenosine (beta-D-Adenosine),
Cladribine (2-chloro-2′-deoxy-adenosine)		2件: Adenosine (Adenosine),
Cladribine 💬 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
62-CdA, 2-chloro-2’-deoxy-ß-D-adenosine2件: Adenosine (beta-D-Adenosine),
Cladribine (2-chloro-2′-deoxy-adenosine)		2件: Adenosine (Adenosine),
Cladribine 💬 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
72-chloro-2'-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine (beta-D-Adenosine),
Cladribine (2-chloro-2′-deoxy-adenosine)		2件: Adenosine (Adenosine),
Cladribine 💬 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
82-chloro-2'-deoxy-ß-D-adenosine (2-CdA)2件: Adenosine (beta-D-Adenosine),
Cladribine (2-chloro-2′-deoxy-adenosine)		2件: Adenosine (Adenosine),
Cladribine 💬 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
92-chloro-2?-deoxy-beta-D-adenosine1件: Adenosine (beta-D-Adenosine)1件: Adenosine (Adenosine) 💬 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		13件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
102-chloro-2?-deoxy-ß-D-adenosine1件: Adenosine (beta-D-Adenosine)1件: Adenosine (Adenosine) 💬 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		13件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
112-chloro-2’-deoxy-beta-D-adenosine1件: Adenosine (beta-D-Adenosine)1件: Adenosine (Adenosine) 💬 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		13件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
122-chloro-2’-deoxy-beta-D-adenosine (2-CdA)2件: Adenosine (beta-D-Adenosine),
Cladribine (2-chloro-2′-deoxy-adenosine)		2件: Adenosine (Adenosine),
Cladribine 💬 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
132-chloro-2’-deoxy-ß-D-adenosine1件: Adenosine (beta-D-Adenosine)1件: Adenosine (Adenosine) 💬 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		13件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
142-chloro-2’-deoxy-ß-D-adenosine (2-CdA)2件: Adenosine (beta-D-Adenosine),
Cladribine (2-chloro-2′-deoxy-adenosine)		2件: Adenosine (Adenosine),
Cladribine 💬 		5件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3,
RRM1 💬 		17件: Alcoholism, Calcium signaling pathway, Drug metabolism - other enzymes, Glutathione metabolism, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Purine metabolism, Pyrimidine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 13 💬
15Adenosine1件: Adenosine (beta-D-Adenosine)1件: Adenosine (Adenosine) 💬 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		13件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬4件: 13, 57, 58, 65 💬
16Autologous ex vivo gene therapy products based on the EFS LV encoding for the human adenosine deaminase (ADA) gene (EFS-ADA LV)1件: Adenosine (beta-D-Adenosine)1件: Adenosine (Adenosine) 💬 4件: ADORA1,
ADORA2A,
ADORA2B,
ADORA3 💬 		13件: Alcoholism, Calcium signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 65 💬